Suppr超能文献

大分割全乳放疗:当前观点

Hypofractionated whole breast radiotherapy: current perspectives.

作者信息

Koulis Theodora A, Phan Tien, Olivotto Ivo A

机构信息

Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada.

出版信息

Breast Cancer (Dove Med Press). 2015 Oct 27;7:363-70. doi: 10.2147/BCTT.S81710. eCollection 2015.

Abstract

Adjuvant radiotherapy (RT) is an important part of breast cancer management but the dose and fractionation schedules used are variable. A total of 50 Gy in 25 daily fractions delivered over 5 weeks is often considered the "standard" adjuvant RT prescription. Hypofractionated regimes such as 42.5 Gy in 16 daily fractions or 40 Gy in 15 daily fractions following breast-conserving surgery have proven to be equally effective and achieve similar or better cosmetic and normal tissue outcomes for both invasive and in situ diseases and when treating the regional nodes. Hypofractionation is more convenient for patients and less costly. However, certain patients at higher risk of RT late effects may benefit from a less intense, even more extended fractionation schedule. This review describes the indications for whole breast hypofractionated adjuvant RT for patients with breast cancer following breast-conserving surgery and proposes that hypofractionation should be the new "standard" for adjuvant breast cancer RT.

摘要

辅助放疗(RT)是乳腺癌治疗的重要组成部分,但所使用的剂量和分割方案各不相同。在5周内每天分割25次给予总计50 Gy的剂量通常被视为“标准”辅助放疗处方。保乳手术后采用超分割方案,如16次每日分割给予42.5 Gy或15次每日分割给予40 Gy,已被证明同样有效,并且对于浸润性和原位疾病以及治疗区域淋巴结时,能取得相似或更好的美容效果和正常组织结局。超分割对患者更方便且成本更低。然而,某些放疗晚期效应风险较高的患者可能会从强度较低、甚至更延长的分割方案中获益。本综述描述了保乳手术后乳腺癌患者全乳超分割辅助放疗的适应证,并提出超分割应成为辅助性乳腺癌放疗的新“标准”。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8271/4629948/64569e4a7f40/bctt-7-363Fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验